Health and Fitness Health and Fitness
Tue, November 29, 2011
[ Tue, Nov 29th 2011 ] - Market Wire
Watson's Generic Yaz(R) Receives FDA Approval
[ Tue, Nov 29th 2011 ] - Market Wire
CryoLife to Present at 6th Annual Canaccord Genui .. ular, Aesthetics & Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
Health Net Hosts 20th Annual Celebration of Children
[ Tue, Nov 29th 2011 ] - Market Wire
Dendreon and Human Genome Sciences - Ready to Turn Fortunes Around
[ Tue, Nov 29th 2011 ] - Market Wire
WeedMaps Announces Acquisition of Domain Name Marijuana.com
[ Tue, Nov 29th 2011 ] - Market Wire
EnteroMedics to Present at the Canaccord Genuity .. ar, Aesthetics and Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
FDA Accepts ELIQUIS (apixaban) New Drug Applicati .. ion of Stroke and Systemic Embolism in Patients w
[ Tue, Nov 29th 2011 ] - Market Wire
Marina Biotech and Debiopharm SA Achieve Key Pre-Clinical Milestone in Bladder Cancer Program
[ Tue, Nov 29th 2011 ] - Market Wire
Cytokinetics Announces Opening of Third Phase II .. 57 in Patients With Amyotrophic Lateral Sclerosis
[ Tue, Nov 29th 2011 ] - Market Wire
Warnex Announces Resignation of Its President &;; CEO
[ Tue, Nov 29th 2011 ] - Market Wire
Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference
[ Tue, Nov 29th 2011 ] - Market Wire
Inhibitex Reports Recent Clinical and Corporate Developments
[ Tue, Nov 29th 2011 ] - Market Wire
Omeros Announces Submission to European Medicines .. ic Investigation Plan Letter of Intent for OMS302
[ Tue, Nov 29th 2011 ] - Market Wire
Compugen and DiscoveRx Form Collaboration to Comm .. alize Novel Peptide Ligands for GPCR Drug Targets
[ Tue, Nov 29th 2011 ] - Market Wire
Warnex Closes Transactions to Amend the Terms of .. ing Debentures and to Obtain Additional Financing
[ Tue, Nov 29th 2011 ] - Market Wire
Horizon Pharma Announces U.S. Food and Drug Admin .. RA(R) New Drug Application for Review for the Tre
[ Tue, Nov 29th 2011 ] - Market Wire
ONGLYZA (saxagliptina) aprobado para su utilizaci .. combinacin con insulina (con o sin metformina) en
[ Tue, Nov 29th 2011 ] - Market Wire
Radient Pharmaceuticals Corporation Completes Res .. al Investors to Limit Conversions and Stock Sales
[ Tue, Nov 29th 2011 ] - Market Wire
Perceptive Informatics DataLabs EDC Solution Ranks Highest in Overall Satisfaction
[ Tue, Nov 29th 2011 ] - Market Wire
Exelixis Announces Webcast of Annual R&D Day on This Thursday, December 1
[ Tue, Nov 29th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Mon, November 28, 2011
[ Mon, Nov 28th 2011 ] - Market Wire
FMX Ventures Inc. Announces Posting of Filing Sta .. ement and Receipt of Conditional Listing Approval
[ Mon, Nov 28th 2011 ] - Market Wire
WSPR Szczecin, Largest Polish EMS Agency Adds ZOL .. rated Automated Compression-Defibrillation System
[ Mon, Nov 28th 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. nvestment in Hospira, Inc. to Inquire About the L
[ Mon, Nov 28th 2011 ] - Market Wire
Gentiva Health Services Announces Credit Agreement Amendment
[ Mon, Nov 28th 2011 ] - Market Wire
Paladin Announces Agreement for Novel OTC Product to Prevent Travellers' Diarrhea
[ Mon, Nov 28th 2011 ] - Market Wire
Gilman Law LLP Announces Securities Fraud Lawsuit Against Hospira, Inc.
[ Mon, Nov 28th 2011 ] - Market Wire
AspenBio Reports Data From AppyScore Pilot Study and Planned Product Pathway
[ Mon, Nov 28th 2011 ] - Market Wire
Qualitest Pharmaceuticals Receives FDA Approval f .. gestrel and Ethinyl Estradiol Tablets, USP), 0.05
[ Mon, Nov 28th 2011 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. bcast of Presentation at Piper Jaffray Conference

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference


Published on 2011-11-28 13:10:17 - Market Wire
  Print publication without navigation


ROCKVILLE, Md.--([ ])--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the Piper Jaffray 23rd Annual Health Care Conference will be webcast and may be accessed at [ www.hgsi.com ].

A member of Human Genome Sciencesa senior management team will present a corporate overview on Wednesday, November 30, 2011, at 9:30 AM Eastern time. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

ABOUT HUMAN GENOME SCIENCES

Human Genome Sciences exists to place new therapies into the hands of those battling serious disease.

For more information about HGS, please visit the Companyas web site at [ www.hgsi.com ]. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to [ clinicaltrialsinfo@hgsi.com ] or by calling HGS at (240) 314-4430.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. Other trademarks referenced are the property of their respective owners.

Contributing Sources